Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009
Explore this paper's citation graph
Summary
NAFLD is becoming a major cause of HCC in the United States and is associated with shorter survival time, more advanced tumor stage, and lower possibility of receiving a LT.
- Type
- article
- Published
- 2015-12-01
- Cited by
- 740
- References
- 28
- OpenAlex
- https://openalex.org/W1776128289
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:205898316
Keywords
Medicine, Internal medicine, Hepatocellular carcinoma, Nonalcoholic fatty liver disease, Gastroenterology
References
- Improving Hepatocellular Carcinoma Screening: Applying lessons from colorectal cancer screening
- Non-Alcoholic Fatty Liver Disease and Hepatocellular Cancer: A Systematic Review
- Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma
- Non‐alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis
- Systematic review with meta‐analysis: non‐alcoholic steatohepatitis ‐ a case for personalised treatment based on pathogenic targets
- Overview of the SEER-Medicare Data: Content, Research Applications, and Generalizability to the United States Elderly Population
- Changing hepatocellular carcinoma incidence and liver cancer mortality rates in the United States
- The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis
- NAFLD may be a common underlying liver disease in patients with hepatocellular Carcinoma in the United States
- Metabolic syndrome increases the risk of primary liver cancer in the United States: a population-based case-control study
- Utilization of Hepatocellular Carcinoma Surveillance Among American Patients: A Systematic Review
- Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis
- Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question.
- The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
- Nonalcoholic fatty liver disease: a precursor of the metabolic syndrome.
- Early Detection, Curative Treatment, and Survival Rates for Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis: A Meta-analysis
- Surveillance for hepatocellular carcinoma: how can we do better?
- Hepatocellular Carcinoma Screening Practices in the Department of Veterans Affairs: Findings from a National Facility Survey
- Prevalence of Prediabetes and Diabetes and Metabolic Profile of Patients With Nonalcoholic Fatty Liver Disease (NAFLD)
- Nonalcoholic Fatty Liver Disease, Diabetes, Obesity, and Hepatocellular Carcinoma
Cited by
- Nonalcoholic fatty liver disease
- How to Diagnose Nonalcoholic Fatty Liver Disease
- Inhibition of the Cell Death Pathway in Nonalcoholic Steatohepatitis (NASH)-Related Hepatocarcinogenesis Is Associated with Histone H4 lysine 16 Deacetylation
- Epigenome-Wide Association Studies Provide Insight into the Pathogenesis of Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis.
- Suppressing NLRP2 expression accelerates hepatic steatosis: A mechanism involving inflammation and oxidative stress.
- Impact of contrast ultrasound diagnosis for patients with liver cancer
- Fatty liver disease
- Capitalising on improved rates of diagnosis of early hepatocellular carcinoma.
- HEDGEHOG signal in Hepatocytes mediates Macrophage Recruitment: A New Mechanism and Potential Therapeutic Target for Fatty Liver Disease
- Nonalcoholic fatty future disease.
- Fibrosis assessment: impact on current management of chronic liver disease and application of quantitative invasive tools
- Epidemiology and natural history of non-alcoholic fatty liver disease.
- Insights from Genome-Wide Association Analyses of Nonalcoholic Fatty Liver Disease
- Non-alcoholic Fatty Liver Disease (NAFLD) is associated with impairment of Health Related Quality of Life (HRQOL)
- EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma.
- Not routine screening, but vigilance for chronic liver disease in patients with type 2 diabetes.
- Hepatocellular Carcinoma in Obesity, Type 2 Diabetes, and NAFLD
- Nonalcoholic Fatty Liver Disease: Key Considerations Before and After Liver Transplantation
- The Role of Nuclear Receptors in the Pathophysiology, Natural Course, and Drug Treatment of NAFLD in Humans
- Contribution of Alcoholic and Nonalcoholic Fatty Liver Disease to the Burden of Liver-Related Morbidity and Mortality.
Related papers
- Small intestinal bacterial overgrowth and nonalcoholic fatty liver disease
- Patterns of service utilisation within Australian hepatology clinics: high prevalence of advanced liver disease
- Liver Disease in Injection Drug Users with Hepatitis C, With and Without HIV Coinfection
- Hepatitis C treatment for patients post liver transplant
- Hospitalizations and costs associated with hepatitis C and advanced liver disease continue to increase.
- Hepatitis C and human immunodeficiency virus infection
- Hepatitis C and human immunodeficiency virus infection
- Management of HBV- and HCV-induced end stage liver disease